DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Camptothecin is an investigational drug.
There have been 99 clinical trials for Camptothecin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 1998.
The most common disease conditions in clinical trials are Lung Neoplasms, Small Cell Lung Carcinoma, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Astex Pharmaceuticals, and University of New Mexico.
Recent Clinical Trials for Camptothecin
|A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors||National Cancer Institute (NCI)||Phase 1/Phase 2|
|How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix||Assiut University||Phase 2|
|Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy in Advanced or Metastatic Cancers of the Stomach and Intestines||National Cancer Institute (NCI)||Phase 1|